Identification of susceptible HLA class II co-amoxiclav genotypes based on the analysis of drug-specific T-cells from patients with liver injury

Documenti analoghi

• Characterization of amoxicillin and clavulanic-acid-responsive CD4+ And CD8+ T-cells in patients with co-amoxiclav-induced liver injury
  di: Kim, Seung-Hyun, et al.
  Pubblicazione: (2014)
• HLA-DQ restricted activation of nitroso-sulfamethoxazole-specific CD4+ T-lymphocytes
  di: Ogese, Monday, et al.
  Pubblicazione: (2014)
• Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
  di: Faulkner, Lee, et al.
  Pubblicazione: (2014)
• Abs No: HLA-A*31:01 positive hypersensitive patient
  di: Lichtenfels, Maike, et al.
  Pubblicazione: (2014)
• Drug Induced Hypersensitivity and the HLA Complex
  di: Alfirevic, Ana, et al.
  Pubblicazione: (2010)